OCUL stock clocked its best day since early July while FDMT marked its best day since August 2025. ・Clear Street kept its ‘Buy’ rating on Ocular in the hope that the Eyepoint setback may ease ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

4D Molecular Therapeutics, Inc. (FDMT) has been beaten down lately with too much selling pressure. While the stock has lost 26% over the past four weeks, there is light at the end of the tunnel as it ...

Below is Validea's guru fundamental report for 4D MOLECULAR THERAPEUTICS INC (FDMT). Of the 22 guru strategies we follow, FDMT rates highest using our Value Investor model based on the published ...

4D (FDMT) market analysis | revenue trends and price momentum remain in focus. 4D Molecular Therapeutics Inc. (FDMT) closed at $9.66, gaining 2.55% on the session. The stock is trading above its ...

These are known as capital allocation programs. 4D Molecular Therapeutics (NASDAQ:FDMT) does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search ...